4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000061
Chief Medical Officer sold 5,026 shares at $15.00 ($75,398)
- Chief Medical Officer acquired 10,043 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2024-11-11 | Option exercise 10b5-1 | +5,017 | $0.54 | $2,709 | 140,991 | D |
| Rodman David Malcom Chief Medical Officer | 2024-11-11 | Option exercise 10b5-1 | +5,026 | $1.08 | $5,428 | 146,017 | D |
| Rodman David Malcom Chief Medical Officer | 2024-11-11 | Sale 10b5-1 | −5,026 | $15.00 | $75,398 | 140,991 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2024-11-11 | Option exercise · Stock Option 10b5-1 | −5,017 | 10,035 | D | ||
| Rodman David Malcom Chief Medical Officer | 2024-11-11 | Option exercise · Stock Option 10b5-1 | −5,026 | 134,926 | D | ||
| Open-market sales · 5,026 sh · avg $15.00 · $75,398 | |||||||
Loading xslF345X05/wk-form4_1731450331.xml…